Alex Hammacher
Head of Strategic Operations & Corporate Finance
Alex has more than two decades of clinical and corporate finance experience. A former junior doctor, he moved into investment banking in 2007.
He joined OSE in 2019 to lead major corporate finance activities including acquisitions, exits, and public transactions, and manage long term strategic planning.
He has raised equity and debt capital for both private and public companies, and advised on local and cross-border M&A and partnerships whilst at UBS and Lazard in Europe, US and Australia-Pacific. His experience includes both large cap pharma and medtech, early-stage biotech and digital health, as well as cleantech, utilities and infrastructure.
He holds degrees in Medicine, Surgery and Physiological Sciences from the University of Oxford.
WORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting spinouts?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.